Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of 1% GPB Cream in Primary Axillary Hyperhidrosis
NCT03658616Phase 3Completed
- Sponsor
- Dr. August Wolff
- Start
- Sep 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of WO3979 in primary axillary hyperhidrosis (PAH), sponsored by Dr. August Wolff. Started Sep 2018; status: completed.
02
Drugs
WO3979
03
Conditions
primary axillary hyperhidrosis (PAH)
Beyond the preview
Go deeper on NCT03658616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658616.